Letter: DRESS syndrome associated with raltegravir

Dermatology Online Journal

Volumn 17, Issue 8, 2011, Pages

  Zhang, Kevin S ^a   Modi, Gunjan M ^a   Hsu, Sylvia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMLODIPINE; ATORVASTATIN; DARUNAVIR; DIPHENHYDRAMINE; HYDROCHLOROTHIAZIDE; LAMIVUDINE; METHYLPREDNISOLONE; RALTEGRAVIR; RITONAVIR; STEROID; VERAPAMIL; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; DISEASE COURSE; DRESS SYNDROME; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FACE EDEMA; FACE ERYTHEMA; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LABORATORY TEST; LETTER; LYMPHADENOPATHY; MEDICAL HISTORY; PRURITUS; RASH; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80051748562     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009;145:67-72. [PubMed]
2. Peyriere H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155:422-8. [PubMed]
3. Hetherington S, McGuirk S, Powell G, Cutrell A, Naderer O, Spreen B et al. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clin Ther 2001;23:1603-14. [PubMed]
4. Bourezane Y, Salard D, Hoen B, Vandel S, Drobacheff C, Laurent R. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy. Clin Infect Dis 1998;27:1321-2. [PubMed]
5. Angel-Moreno-Maroto A, Suárez-Castellano L, Hernández-Cabrera M, Pérez-Arellano JL. Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure. J Infect 2006;52:e39-e40. [PubMed]
6. Perry MEO, Almaani N, Desai N, Fox J, Larbalestier N, Chilton D. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety. J Int AIDS Soc 2010;13 (Suppl 4): P110.
7. Ward HA, Russo GG, Shrum J. Cutaneous manifestations of antiretroviral therapy. J Am Acad Dermatol 2002;46:284-93. [PubMed]
8. Calista D, Boschini A. Cutaneous side effects induced by indinavir. Eur J Dermatol 2000;10:292-6.